An antidepressant drug used to treat obsessive-compulsive disorder may save patients from sepsis, a University of Virginia School of Medicine professor has found.
Researcher Alban Gaultier, Ph.D., of the Department of Neuroscience and its Center for Brain Immunology and Glia, notes that there is currently no good treatment for sepsis. But fluvoxamine has worked effectively in models to stop the disease. The researchers are focused on the biological process inside cells related to regulating inflammation.
From the March 1, 2019 Issue of McKnight's Long-Term Care News
